Quintela Fandiño, Miguel Angel miguel.quintela@uam.es
Actividades
- Artículos 52
- Libros 0
- Capítulos de libro 0
- Congresos 1
- Documentos de trabajo 0
- Informes técnicos 1
- Proyectos de investigación 0
- Tesis dirigidas 1
- Patentes o licencias de software 0
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
- Bossuyt V
- Provenzano E
- Symmans WF
- Boughey JC
- Coles C
- Curigliano G
- Dixon JM
- Esserman LJ
- Fastner G
- Kuehn T
- Peintinger F
- Von Minckwitz G
- White J
- Yang W
- Badve S
- Denkert C
- MacGrogan G
- Penault-Llorca F
- Viale G
- Cameron D
- Davidson NE
- Piccart M
- Norton L
- Earl H
- Alba E
- Lluch A
- Albanell J
- Amos K
- Becette V
- Biernat W
- Bonnefoi H
- Buzdar A
- Cane P
- Pinder S
- Carson L
- Dickson-Witmer D
- Gong G
- Green J
- Hsu CY
- Tseng LM
Annals Of Oncology (p. 1280-1291) - 1/7/2015
10.1093/annonc/mdv161 Ver en origen
- ISSN 09237534
Targeting the Tumor Stroma in Breast Cancer
- Sanchez-Ruiz J
- Quintela-Fandino M
Current Breast Cancer Reports (p. 71-79) - 28/3/2015
10.1007/s12609-014-0173-9 Ver en origen
- ISSN 19434596
Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: Results of the CNIO-BR002 phase I-trial
- Quintela-Fandino, Miguel
- Bueno, Maria J.
- Lombardia, Luis
- Gil, Marta
- Gonzalez-Martin, Antonio
- Marquez, Raul
- Bratos, Raquel
- Guerra, Juan
- Tan, Eugene
- Lopez, Antonio
- Colomer, Ramon
- Salazar, Ramon;
Molecular Oncology (p. 1719-1728) - 1/12/2014
- ISSN 15747891
- iMarina
Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study)
- Quintela-Fandino, M.
- Urruticoechea, A.
- Guerra, J.
- Gil, M.
- Gonzalez-Martin, A.
- Marquez, R.
- Hernandez-Agudo, E.
- Rodriguez-Martin, C.
- Gil-Martin, M.
- Bratos, R.
- Escudero, M. J.
- Vlassak, S.
- Hilberg, F.
- Colomer, R.;
British Journal Of Cancer (p. 1060-1064) - 1/1/2014
10.1038/bjc.2014.397 Ver en origen
- ISSN 00070920
CX3CL1 promotes breast cancer via transactivation of the EGF pathway
- Tardáguila M, Mira E, García-Cabezas MA, Feijoo AM, Quintela-Fandino M, Azcoitia I, Lira SA, Mañes S
Cancer Research (p. 4461-4473) - 15/7/2013
- ISSN 00085472
- iMarina
In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours
- Quintela-Fandino, M.
- Krzyzanowska, M.
- Duncan, G.
- Young, A.
- Moore, M. J.
- Chen, E. X.
- Stathis, A.
- Colomer, R.
- Petronis, J.
- Grewal, M.
- Webster, S.
- Wang, L.
- Siu, L. L.;
British Journal Of Cancer (p. 1298-1305) - 2/4/2013
10.1038/bjc.2013.64 Ver en origen
- ISSN 00070920
DOVITINIB LACTATE Multikinase Inhibitor Antiongiogenic Agent Oncolytic
- Quintela-Fandino
- M Colomer
- R
Drugs Of The Future (p. 81-89) - 1/1/2013
10.1358/dof.2013.38.2.1918242 Ver en origen
- ISSN 03778282
The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk
- Arpaia, E.
- Blaser, H.
- Quintela-Fandino, M.
- Duncan, G.
- Leong, H. S.
- Ablack, A.
- Nambiar, S. C.
- Lind, E. F.
- Silvester, J.
- Fleming, C. K.
- Rufini, A.
- Tusche, M. W.
- Bruestle, A.
- Ohashi, P. S.
- Lewis, J. D.
- Mak, T. W.;
Oncogene (p. 884-896) - 16/2/2012
10.1038/onc.2011.288 Ver en origen
- ISSN 09509232
Prediction of Response to Targeted Therapies in Lung Cancer Using Dynamic Imaging: Still Far From Clinical Implementation
- Quintela-Fandino, Miguel
- Colomer, Ramon;
Journal Of Clinical Oncology (p. 3716-3718) - 20/9/2011
10.1200/jco.2011.37.1427 Ver en origen
- ISSN 0732183X
- iMarina
- iMarina
Phase I Combination of Sorafenib and Erlotinib Therapy in Solid Tumors: Safety, Pharmacokinetic, and Pharmacodynamic Evaluation from an Expansion Cohort
- Quintela-Fandino, Miguel
- Le Tourneau, Christophe
- Duran, Ignacio
- Chen, Eric X.
- Wang, Lisa
- Tsao, Ming
- Bandarchi-Chamkhaleh, Bizhan
- Pham, Nhu-Ann
- Do, Trevor
- MacLean, Martha
- Nayyar, Rakesh
- Tusche, Michael W.
- Metser, Ur
- Wright, John J.
- Mak, Tak W.
- Siu, Lillian L.;
Molecular Cancer Therapeutics (p. 751-760) - 1/3/2010
10.1158/1535-7163.mct-09-0868 Ver en origen
- ISSN 15357163
Este/a investigador/a no tiene libros.
Este/a investigador/a no tiene capítulos de libro.
Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study
- Quintela-Fandino, M.
- Urruticoechea, A.
- Guerra, J.
- Gil, M.
- Gonzalez-Martin, A.
- Marquez, R.
- Hernandez-Agudo, E.
- Rodriguez-Martin, C.
- Gil, M.
- Bratos, R.
- Escudero, M. J.
- Colomer, R.;
Cancer Research - 15/12/2013
10.1158/0008-5472.sabcs13-pd5-8 Ver en origen
- ISSN 00085472
Este/a investigador/a no tiene documentos de trabajo.
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors
- Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR
Clinical Cancer Research (p. 2257-2269) - 1/1/2022
10.1158/1078-0432.ccr-21-3087 Ver en origen
- ISSN 15573265
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id